M Yldau van der Ende
Overview
Explore the profile of M Yldau van der Ende including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
238
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Du Y, de Bock G, Vonk J, Pham A, van der Ende M, Snieder H, et al.
Eur J Ageing
. 2024 Nov;
21(1):37.
PMID: 39609306
Background: Multimorbidity is linked to poor quality of life, and increased healthcare costs, and multimorbidity risk is potentially mitigated by a healthy lifestyle. This study evaluated the individual and joint...
2.
Koopman M, van der Ende M, Reijnders J, Willemsen R, van Bruggen R, Gratama J, et al.
BMJ Open
. 2024 Oct;
14(10):e079835.
PMID: 39401960
Objective: To explore associations between general health-related problems and subclinical coronary artery disease (CAD), determined by CT coronary calcium score (CT-CCS), in a general population. Design: A cross-sectional design. Setting:...
3.
van de Vegte Y, Eppinga R, van der Ende M, Hagemeijer Y, Mahendran Y, Salfati E, et al.
Nat Commun
. 2023 Aug;
14(1):4646.
PMID: 37532724
Resting heart rate is associated with cardiovascular diseases and mortality in observational and Mendelian randomization studies. The aims of this study are to extend the number of resting heart rate...
4.
van der Ende M, Hendriks T, van de Vegte Y, Lipsic E, Snieder H, van der Harst P
Sci Rep
. 2021 Mar;
11(1):6662.
PMID: 33758211
The sensitivity of electrocardiogram (ECG) criteria to detect left ventricular hypertrophy (LVH) is low, especially in women. We determined sex-specific sensitivities of ECG-LVH criteria, and developed new criteria, using cardiovascular...
5.
van der Ende M, Waardenburg I, Lipsic E, Bos J, Hak E, Snieder H, et al.
Int J Cardiol Hypertens
. 2021 Jan;
6:100042.
PMID: 33447768
Background: It is unknown whether population based single assessment of cardiovascular disease (CVD) risk and feedback to individuals and general practitioners results in initiation of preventive cardiovascular pharmacotherapy in those...
6.
van der Ende M, Juarez-Orozco L, Waardenburg I, Lipsic E, Schurer R, van der Werf H, et al.
J Am Heart Assoc
. 2020 Jun;
9(13):e015519.
PMID: 32573316
Background Myocardial infarction is an important cause of morbidity and mortality in both men and women. Atypical or the absence of symptoms, more prevalent among women, may contribute to unrecognized...
7.
Zwartkruis V, Groenewegen A, Rutten F, Hollander M, Hoes A, van der Ende M, et al.
Prev Med
. 2020 May;
138:106143.
PMID: 32473262
Cardiovascular disease (CVD) often goes unrecognized, despite symptoms frequently being present. Proactive screening for symptoms might improve early recognition and prevent disease progression or acute cardiovascular events. We studied the...
8.
Ntalla I, Weng L, Cartwright J, Hall A, Sveinbjornsson G, Tucker N, et al.
Nat Commun
. 2020 May;
11(1):2542.
PMID: 32439900
The electrocardiographic PR interval reflects atrioventricular conduction, and is associated with conduction abnormalities, pacemaker implantation, atrial fibrillation (AF), and cardiovascular mortality. Here we report a multi-ancestry (N = 293,051) genome-wide...
9.
de las Fuentes L, Sung Y, Noordam R, Winkler T, Feitosa M, Schwander K, et al.
Mol Psychiatry
. 2020 May;
26(6):2111-2125.
PMID: 32372009
Educational attainment is widely used as a surrogate for socioeconomic status (SES). Low SES is a risk factor for hypertension and high blood pressure (BP). To identify novel BP loci,...
10.
van der Ende M, Sijtsma A, Snieder H, van der Harst P
Int J Cardiol
. 2019 Sep;
294:57.
PMID: 31522719
No abstract available.